Stalfort John A III 4
4 · Taysha Gene Therapies, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
Stalfort John A III
Director
Transactions
- Award
Common Stock
2025-06-02+56,623→ 1,155,224 total - Award
Stock Option (right to buy)
2025-06-02+113,246→ 113,246 totalExercise: $2.79Exp: 2035-06-02→ Common Stock (113,246 underlying)
Holdings
- 884,290(indirect: See footnote)
Common Stock
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.
- [F2]The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.
- [F3]The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.